Charles Schwab’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Buy |
258,551
+218,640
| +548% | +$1.11M | ﹤0.01% | 2813 |
|
|
2025
Q1 | $121K | Buy |
39,911
+222
| +0.6% | +$670 | ﹤0.01% | 3317 |
|
|
2024
Q4 | $144K | Buy |
39,689
+13,000
| +49% | +$47.1K | ﹤0.01% | 3366 |
|
|
2024
Q3 | $47K | Hold |
26,689
| – | – | ﹤0.01% | 3418 |
|
|
2024
Q2 | $41.6K | Hold |
26,689
| – | – | ﹤0.01% | 3527 |
|
|
2024
Q1 | $52K | Hold |
26,689
| – | – | ﹤0.01% | 3365 |
|
|
2023
Q4 | $37.6K | Hold |
26,689
| – | – | ﹤0.01% | 3432 |
|
|
2023
Q3 | $42.2K | Hold |
26,689
| – | – | ﹤0.01% | 3418 |
|
|
2023
Q2 | $57.6K | Hold |
26,689
| – | – | ﹤0.01% | 3402 |
|
|
2023
Q1 | $56K | Buy |
26,689
+16,689
| +167% | +$35K | ﹤0.01% | 3332 |
|
|
2022
Q4 | $21.9K | Hold |
10,000
| – | – | ﹤0.01% | 3488 |
|
|
2022
Q3 | $30K | Hold |
10,000
| – | – | ﹤0.01% | 3435 |
|
|
2022
Q2 | $29K | Hold |
10,000
| – | – | ﹤0.01% | 3481 |
|
|
2022
Q1 | $54K | Hold |
10,000
| – | – | ﹤0.01% | 3519 |
|
|
2021
Q4 | $75K | Buy |
+10,000
| New | +$75K | ﹤0.01% | 3473 |
|
|
2016
Q2 | – | Sell |
-1,330
| Closed | -$74K | – | 3142 |
|
|
2016
Q1 | $74K | Buy |
1,330
+29
| +2% | +$1.61K | ﹤0.01% | 3011 |
|
|
2015
Q4 | $179K | Buy |
1,301
+38
| +3% | +$5.23K | ﹤0.01% | 2981 |
|
|
2015
Q3 | $182K | Buy |
+1,263
| New | +$182K | ﹤0.01% | 2972 |
|